Rohto Pharmaceutical Co., Ltd.

Overview

Rohto Pharmaceutical Co., Ltd. is a Japanese multinational corporation specializing in over-the-counter drugs and health products. Founded in 1899 and headquartered in Osaka, Japan, the company has a rich history of providing a wide range of products, including eye care solutions, skincare lines, and functional foods. Rohto has expanded its global presence, operating in over 110 countries and regions, with subsidiaries in the United States, United Kingdom, China, Vietnam, Hong Kong, Indonesia, India, and Bangladesh. The company is listed on the Tokyo Stock Exchange under the ticker symbol 4527. Rohto's investment strategy focuses on venture capital, targeting various stages of company development, from seed to late-stage investments. The company's geographical focus includes Japan, the United States, China, Vietnam, Hong Kong, Indonesia, India, Bangladesh, Austria, and Europe. Rohto's diverse portfolio spans industries such as pharmaceuticals, healthcare, consumer goods, cosmetics, and functional foods. Notable products include Rohto eye drops, the Hada Labo skincare line, and various over-the-counter medications like Oxy. The company emphasizes research and development, with facilities such as the Rohto Research Village in Kyoto, and has made significant strides in expanding its market presence, particularly in emerging markets. Rohto Pharmaceutical Co., Ltd. is committed to improving lives through its high-quality products and innovative solutions. The company's mission is to connect people around the world with their health, aiming to deliver well-being to people globally and realize a sustainable society where individuals can live long, healthy, and happy lives. Rohto continues to focus on research, development, and the delivery of top-tier products that meet the ever-changing needs of its diverse customer base.